Our study has found that there is a significant difference in the expression levels of M6A-related genes ZC3H13, WTAP, METTL14, and HNRNPC between the high and low risk subgroups, which may provide new directions and ideas for the treatment of CESC. This evidence concerns the gene WTAP and cervical squamous cell carcinoma.